학술논문
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 15 February 2024, 42(5):1071-1077)
Subject
Language
English
ISSN
18732518
0264410X
0264410X